medigraphic.com
Instituto de Seguridad y Servicios Sociales de los Trabajadores del Estado

2016, Number 2

<< Back

Rev Esp Med Quir 2016; 21 (2)

Brucellosis lumbar spine: another cause of back pain

Rodríguez GRM, Hinojosa MLM, Estrada RB

Language: Spanish
References: 14
Page: 72-76
PDF size: 635.86 Kb.


ABSTRACT

Brucellosis is a disease that mainly affects developing countries. This zoonotic disease is mainly transmitted through the digestive tract, by consuming unpasteurized dairy products, but is also common in employees of breeding farms and slaughterhouses. It is caused by different species of Brucella. Consider a female patient who lived in a rural area (municipality of Galeana, Nuevo Leon), who started with progressive lower back pain without a traumatic origin until she was left incapacitated. In addition, she suffered from polyarthralgia which was initially treated at home with simple analgesics without improvement which is why she is being referred for your care and handling. This case is presented for literary review to discuss conservative methods, and where indicated, surgery.


REFERENCES

  1. Norma Oficial Mexicana 022-SSA2-2010 para la Prevención y Control de la Brucelosis en el Humano. Guía para el Diagnóstico y Tratamiento del Paciente con Brucelosis.

  2. Campbell’s Operative Orthopaedics, 11e. S. Terry Canale, MD, James H. Beaty, MD Elsevier Imprint, Spine Vol 4. Chapter 40 Pag. 1929-1960.

  3. Memish ZA, Balkhy HH. Brucellosis and international travel. J Travel Med. 2004;11:49-55.

  4. Harrison’s Principles of internal medicine, 17th ed The Mcgraw-Hill, Vol. 1. Chapter 150 Brucelosis Pag. 973-976.

  5. Buchanan TM, Faber LC. 2-mercaptoethanol brucella agglutination test: usefulness for predicting recovery from brucellosis. Journal of Clinical Microbiology. 1980;11(6):691-693.

  6. Mantur B, Parande A, Amarnath S. ELISA versus conventional methods of diagnosing endemic brucellosis. Am J Trop Med Hyg. 2010;83(2):314-318. 2005;11:221-225.

  7. Morata P, Queipo-Ortuno MI, Reguera JM, Miralles F, Lopez-Gonzalez J, Colmenero D. Diagnostic yield of a PCR assay in focal complications of brucellosis. J Clin Microbiol. 2001;39(10):3743-3746.

  8. Queipo-Ortuño MI, Morata P, Manchado P. Rapid diagnosis of human brucellosis by peripheral-blood PCR assay. J Clin Microbiol. 1997;35(11):2927-2930.

  9. Skalsky K, Yahav D, Bishara J. Treatment of human brucellosis: systematic review and meta-analysis of randomized controlled trials. BMJ|ON LINE FIRST. 2008:1-8.

  10. Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ. Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations. Policy Forum. 2007;4(12):1872-1878.

  11. Falagas ME, Bliziotis IA. Quinolones for treatment of human brucellosis: critical review of the evidence from microbiological and clinical studies. Antimicrob Agents Chemother. 2006; 50 (1): 22-33.

  12. Karabay O, Sencan I, Kayas D, Şahin I. Ofl oxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial. BMC Infect Dis. 2004;4(18).

  13. Bodur H, Erbay A, Colpan A, Akıncı E. Brucellar spondylitis. Rheumatol Int. 2004;24:221-226.

  14. Horta CL. Prevalencia de brucelosis en columna. Evolución Clínica y Manejo Quirúrgico. Coluna/Columna. 2013;12(1):57-60.




2020     |     www.medigraphic.com